Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 4, 2011, Pages 932-940

  van deer Pol, Pieter ^a   Roos, Anja ^b   Berger, Stefan P ^a   Daha, Mohamed R ^a   van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Hypoxia; Ischemia; Kidney; Reperfusion injury

Indexed keywords

ACID PHOSPHATASE; COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN M; LECTIN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; COMPLEMENT ACTIVATION; CORRELATIONAL STUDY; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY TUBULE CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION;

EID: 79954472448     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00509.2010     Document Type: Article

References (37)

1. Berger SP, Roos A, Mallat MJ, Schaapherder AF, Doxiadis II, van Kooten C, Dekker FW, Daha MR, de Fijter JW. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 18: 2416-2422, 2007.
2. Burne-Taney MJ, Ascon DB, Daniels F, Racusen L, Baldwin W, Rabb H. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171: 3210-3215, 2003.
3. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA. In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 128: 1659-1663, 1982.
4. Castellano G, Melchiorre R, Loverre A, Ditonno P, Montinaro V, Rossini M, Divella C, Battaglia M, Lucarelli G, Annunziata G, Palazzo S, Selvaggi FP, Staffieri F, Crovace A, Daha MR, Mannesse M, van WS, Paolo SF, Grandaliano G. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol 176: 1648-1659, 2010.
5. Chan RK, Verna N, Afnan J, Zhang M, Ibrahim S, Carroll MC, Moore FD Jr. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery 139: 236-243, 2006.
6. Ciurana CL, Hack CE. Competitive binding of pentraxins and IgM to newly exposed epitopes on late apoptotic cells. Cell Immunol 239: 14-21, 2006.
7. Ciurana CL, Zwart B, van Mierlo G, Hack CE. Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM. Eur J Immunol 34: 2609-2619, 2004.
8. Collard CD, Vakeva A, Bukusoglu C, Zund G, Sperati CJ, Colgan SP, Stahl GL. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 96: 326-333, 1997.
9. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, Buras JA, Meri S, Stahl GL. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 156: 1549-1556, 2000.
10. de Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 165: 1677-1688, 2004.
11. Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, Berger SP. Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol 295: F1397-F1403, 2008.
12. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 130: 41-50, 2009.
13. Kemper C, Atkinson JP, Hourcade DE. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 28: 131-155, 2010.
14. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. I-PLA2 activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196: 655-665, 2002.
15. Krijnen PA, Ciurana C, Cramer T, Hazes T, Meijer CJ, Visser CA, Niessen HW, Hack CE. IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 58: 382-388, 2005.
16. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 176: 2950-2957, 2006.
17. Moller-Kristensen M, Wang W, Ruseva M, Thiel S, Nielsen S, Taka-hashi K, Shi L, Ezekowitz A, Jensenius JC, Gadjeva M. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 61: 426-434, 2005.
18. Mollnes TE, Kirschfink M. Strategies of therapeutic complement inhibition. Mol Immunol 43: 107-121, 2006.
19. Nauta AJ, Daha MR, van Kooten C, Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 24: 148-154, 2003.
20. Padilla ND, Ciurana C, van Oers J, Ogilvie AC, Hack CE. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. J Immunol Methods 293: 1-11, 2004.
21. Pagtalunan ME, Olson JL, Tilney NL, Meyer TW. Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 10: 366-373, 1999.
22. Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ. Injury in renal ischemia-reperfusion is independent from immunoglobu-lins and T lymphocytes. Am J Physiol Renal Physiol 282: F352-F357, 2002.
23. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 364: 1814-1827, 2004.
24. Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotech-nol 25: 1265-1275, 2007.
25. Roos A, Bouwman LH, Munoz J, Zuiverloon T, Faber-Krol MC, van den Houten FC, Klar-Mohamad N, Hack CE, Tilanus MG, Daha MR. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 39: 655-668, 2003.
26. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57, 1994.
27. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ische-mic acute renal failure in mice. J Immunol 170: 1517-1523, 2003.
28. Thurman JM, Ljubanovic D, Royer PA, Kraus DM, Molina H, Barry NP, Proctor G, Levi M, Holers VM. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ische-mia/reperfusion. J Clin Invest 116: 357-368, 2006.
29. Thurman JM, Royer PA, Ljubanovic D, Dursun B, Lenderink AM, Edelstein CL, Holers VM. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 17: 707-715, 2006.
30. Trouw LA, Seelen MA, Visseren R, Duijs JM, Benediktsson H, de Heer E, Roos A, van Kooten C, Daha MR. Anti-C1q autoantibodies in murine lupus nephritis. Clin Exp Immunol 135: 41-48, 2004.
31. Turman MA, Bates CM, Mathews A, Haun SE. Effect of extracellular calcium on survival of human proximal tubular cells exposed to hypoxia. Ren Fail 17: 421-435, 1995.
32. van Kooten C, Gerritsma JS, Paape ME, van Es LA, Banchereau J, Daha MR. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 51: 711-721, 1997.
33. Walport MJ. Complement. First of two parts. N Engl J Med 344: 1058-1066, 2001.
34. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD Jr, Carroll MC. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci US A 101: 3886-3891, 2004.
35. Zhang M, Takahashi K, Alicot EM, Vorup-Jensen T, Kessler B, Thiel S, Jensenius JC, Ezekowitz RA, Moore FD, Carroll MC. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 177: 4727-4734, 2006.
36. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363-1371, 2000.
37. Zhou W, Medof ME, Heeger PS, Sacks S. Graft-derived complement as a mediator of transplant injury. Curr Opin Immunol 19: 569-576, 2007.